SNT
Click for more information
0.00% 3.5¢ syntara limited

re: Ann: Pharmaxis Announces Positive Combine... Europe? Orphan...

  1. wiljon
    163 Posts.
    clock Created with Sketch.
    22/10/10
    13:56
    Post #: 7370067
    re: Ann: Pharmaxis Announces Positive Combine... Europe
    ? Orphan drug designation
    ? EMA submission Oct 2009
    ? EMA response anticipated Q4 2010
    ? First sales 1H 2011
    USA
    ? Orphan drug designation
    ? Headline data June 2010
    ? NDA submission 1H 2011
    ? FDA response anticipated 1H 2012
    PXS Price at posting: $2.73 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN Raiden gears up for exploration in final quarter of 2024
right-arrow Created with Sketch.
NEWS Talking trends: The five shaping investment in 2024
right-arrow Created with Sketch.
PLS Pilbara blames low lithium prices for 89% drop in profit for FY24
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions
right-arrow Created with Sketch.
KPO KALiNA Power inks MOU for natgas powered data centres using carbon capture as AI energy use grows
right-arrow Created with Sketch.
JAV Javelin increases the resource of Coogee in WA by 158%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $45.16M
Open High Low Value Volume
3.6¢ 3.6¢ 3.3¢ $58.54K 1.668M

Buyers (Bids)

No. Vol. Price($)
1 5226 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 969288 2
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.